The proportions of CD45RA− CD8+ memory cells within the viable T cell gate were comparable between these cohorts (p = 0.948; median: 10.1%, interquartile range (IQR): 8.1–11.5, median: 10.5%, IQR: 8.3–12.5; and median: 10.0%, IQR: 8.0–12.6, for HC, MS and NTZ-MS groups, respectively). The gene discussed is CD8A; the disease is myeloid sarcoma.